Related Experiment Video
Updated: Jun 15, 2026

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it]
11. interní hemato-onkologická klinika 1. LF a VFN a UHKT, Praha. pavel.klener@ruk.cuni.cz
Abstract:
Angiogenesis is a complex process which is critical for the growth, invasion and metastasis of tumors. In the past ten years numerous new agents have been developed as angiogenesis inhibitors. In the review, angiogenesis inhibitors are classified by their targeted area of the angiogenic process. The role of VEGF and its receptors is described in detail, but other antiangiogenic strategies such as inhibition of endothelial proliferation, inhibition of matrix metalloproteinases and use of vascular disrupting agents are also reviewed.
Insights
Angiogenesis inhibitors target tumor growth and spread. This review classifies these agents by their mechanism, focusing on VEGF and other anti-angiogenic strategies for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Context:
- Tumor growth, invasion, and metastasis are critically dependent on angiogenesis.
- Significant advancements in developing angiogenesis inhibitors have occurred over the last decade.
- Understanding the multifaceted nature of angiogenesis is key to developing effective cancer therapies.
Purpose:
- To classify and review current angiogenesis inhibitors based on their targeted mechanisms within the angiogenic process.
- To detail the role of Vascular Endothelial Growth Factor (VEGF) and its receptors in tumor angiogenesis.
- To provide a comprehensive overview of diverse anti-angiogenic strategies.
Summary:
- This review categorizes angiogenesis inhibitors according to their specific targets in the angiogenic cascade.
- It elaborates on the significance of the VEGF pathway and its receptors.
- Other strategies discussed include inhibiting endothelial cell proliferation, matrix metalloproteinases, and the use of vascular disrupting agents.
Impact:
- Provides a structured classification of angiogenesis inhibitors for researchers and clinicians.
- Highlights key molecular targets and pathways for anti-cancer drug development.
- Offers insights into a range of therapeutic strategies beyond VEGF inhibition for combating cancer progression.
More Related Videos
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...